Opendata, web and dolomites

Ocean Medicines SIGNED

Ocean Medicines

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Ocean Medicines" data sheet

The following table provides information about the project.

Coordinator
CONSIGLIO NAZIONALE DELLE RICERCHE 

Organization address
address: PIAZZALE ALDO MORO 7
city: ROMA
postcode: 185
website: www.cnr.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.oceanmedicines.eu
 Total cost 360˙000 €
 EC max contribution 360˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2015
 Funding Scheme MSCA-RISE
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) coordinator 45˙000.00
2    EPI-C SRL IT (NAPOLI) participant 54˙000.00
3    SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA PT (SAGRES) participant 54˙000.00
4    UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET NO (TROMSO) participant 54˙000.00
5    FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA ES (ARMILLA GRANADA) participant 49˙500.00
6    STAZIONE ZOOLOGICA ANTON DOHRN IT (NAPOLI) participant 45˙000.00
7    THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN UK (ABERDEEN) participant 36˙000.00
8    BIOSEARCH SRL IT (NAPOLI) participant 22˙500.00
9    ECOAST BE (OOSTENDE) participant 0.00
10    SEALIFE PHARMA GMBH AT (TULLN) participant 0.00
11    UNIVERSITY OF THE WESTERN CAPE ZA (CAPE TOWN) partner 0.00

Map

 Project objective

Marine organisms have the capacity to produce a variety of biologically potent natural products. Such novel molecules have new mechanisms of action and therefore could be used to treat human diseases and enhance the quality of life, especially in the ageing segment of the population. However, although there is growing interest in marine natural products (MNP) as potential therapeutic agents for human age-related diseases, few MNPs have reached clinical trials and the market. To fully exploit these promising biological resources, new strategies in the pipeline as well as a new cohort of cross-disciplinary trained scientists are needed to overcome existing bottlenecks and ensure the production of high value biomolecules. Ocean Medicines is a network of academic, research centres and SMEs across Europe, with proven experience in higher education, training and endowed with state-of-the art scientific and technical expertise and infrastructures. Our aim is to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium. To achieve this a secondment programme will be set up to prepare a new generation of marine biodiscovery scientists that will be trained on how to isolate compounds from bioactive bacteria/microalgae and take these through to semi-industrial scale-up for further development and toxicity testing at the pre-clinical level. The Ocean Medicines programme also considers commercialization, innovation and entrepreneurship activities including how to start a new business and how to favour an industrial career to seconded researchers. We are confident that the establishment of this international research network, with its synergistic effects, will significantly contribute to advance all of the involved labs to the top level in the field of marine drug discovery.

 Deliverables

List of deliverables.
Final Workshop Other 2020-02-12 15:37:37
Dissemination Websites, patent fillings, videos etc. 2020-02-12 15:37:32
Business model development best practices for new companies Documents, reports 2020-02-12 08:58:29
Case studies failed ventures Documents, reports 2020-02-12 08:58:28
Case studies successful ventures Documents, reports 2020-02-12 08:58:28
website Websites, patent fillings, videos etc. 2020-02-12 08:58:28
Project meetings Other 2020-02-12 08:58:28

Take a look to the deliverables list in detail:  detailed list of Ocean Medicines deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero, Gianluigi Franci
Sonoporation by microbubbles as gene therapy approach against liver cancer
published pages: , ISSN: 1949-2553, DOI: 10.18632/oncotarget.25875
Oncotarget 9/63 2020-02-12
2018 Federica Sarno, Chiara Papulino, Gianluigi Franci, Jeanette H. Andersen, Bastien Cautain, Colombina Melardo, Lucia Altucci, Angela Nebbioso
3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.01006
Frontiers in Pharmacology 9 2020-02-12
2018 Mariarosaria Conte, Raffaele De Palma, Lucia Altucci
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
published pages: 65-74, ISSN: 1357-2725, DOI: 10.1016/j.biocel.2018.03.004
The International Journal of Biochemistry & Cell Biology 98 2020-02-12
2018 Emiliana Tortorella, Pietro Tedesco, Fortunato Palma Esposito, Grant January, Renato Fani, Marcel Jaspars, Donatella de Pascale
Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives
published pages: 355, ISSN: 1660-3397, DOI: 10.3390/md16100355
Marine Drugs 16/10 2020-02-12
2019 Marco Miceli, Adele Cutignano, Mariarosaria Conte, Raffaella Ummarino, Alessandra Romanelli, Menotti Ruvo, Marilisa Leone, Flavia Anna Mercurio, Nunzianna Doti, Emiliano Manzo, Giovanna Romano, Lucia Altucci, Adrianna Ianora
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells
published pages: 625, ISSN: 1660-3397, DOI: 10.3390/md17110625
Marine Drugs 17/11 2020-02-12
2019 Valeria Di Dato, Federica Di Costanzo, Roberta Barbarinaldi, Anna Perna, Adrianna Ianora, Giovanna Romano
Unveiling the presence of biosynthetic pathways for bioactive compounds in the Thalassiosira rotula transcriptome
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-46276-8
Scientific Reports 9/1 2020-02-12
2018 Fortunato Palma Esposito, Colin J. Ingham, Raquel Hurtado-Ortiz, Chantal Bizet, Deniz Tasdemir, Donatella de Pascale
Isolation by Miniaturized Culture Chip of an Antarctic bacterium Aequorivita sp. with antimicrobial and anthelmintic activity
published pages: e00281, ISSN: 2215-017X, DOI: 10.1016/j.btre.2018.e00281
Biotechnology Reports 20 2020-02-12
2018 Paulina Corral, Fortunato Palma Esposito, Pietro Tedesco, Angela Falco, Emiliana Tortorella, Luciana Tartaglione, Carmen Festa, Maria Valeria D’Auria, Giorgio Gnavi, Giovanna Cristina Varese, Donatella de Pascale
Identification of a Sorbicillinoid-Producing Aspergillus Strain with Antimicrobial Activity Against Staphylococcus aureus: a New Polyextremophilic Marine Fungus from Barents Sea
published pages: , ISSN: 1436-2228, DOI: 10.1007/s10126-018-9821-9
Marine Biotechnology 2020-02-12

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCEAN MEDICINES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OCEAN MEDICINES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

ROVER (2020)

RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION

Read More  

OPEN (2019)

Outcomes of Patients’ Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology

Read More  

MAIL (2019)

Identifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy

Read More